Home
	Current Research Projects
	Facilities
	Projects for Students
	Recent Publications
	News
	Contact Us

Change Text Size +
Change Text Size -

Current Research Projects Summary

• Phase I clinical evaluation of immune therapy with dendritic cells pulsed with ?-galactosylceramide and tumour antigens in Stage IV metastatic melanoma
• Phase I evaluation of immune therapy with ex-vivo expanded and activated gamma- delta T cells
  • Study 1 - Low grade B lineage haematological malignancies
  • Study 2 – Solid tumours
• Evaluation of the destination of ex-vivo expanded and activated gamma- delta T cells after administration to patients with metastatic malignancy
• Evaluation of the effects of cryopreservation on antitumour activities of in-vitro activated and expanded human gamma-delta T cells
• In vitro studies of combination antitumour therapy involving cytotoxic immune effector cells and other cancer treatments

Other Research Activities

External Clinical Trials
Dr Nicol is a member of the Australasian Leukaemia and Lymphoma Group, allowing enrolment of patients at Greenslopes Hospital in national studies of treatment for leukaemia, myeloma and lymphoma. In addition, the Gallipoli Research Centre is expanding its clinical trial unit to facilitate enrolment of patients in a variety of industry-based clinical trials evaluating recently-developed cancer therapies.

Collaborations with Other Research Groups and Organisations

• Medinet, Japan
• Pharmaceutical Division of Kirin
• Yokohama City University, Japan
• Novartis
• Australian Leukaemia and Lymphoma Group